CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
OPERATING ACTIVITIES
Net loss	$ (1,755)	$ (1,609)
Non cash items:
Amortization	205	179
Non-cash interest expense	68	0
Non-cash stock-based compensation	0	35
Change in other operating items:
Other current assets	26	93
Accounts payable	(52)	(5)
Other accrued liabilities	(53)	48
Cash flows used in operating activities	(1,561)	(1,259)
INVESTING ACTIVITIES
Cash flows provided by investing activities	0	0
FINANCING ACTIVITIES
Sale of Commmon Stock	1,013	0
Pay-off of Convertible Promissory Notes	(1,000)
Issuance of Secured Debt, net of issuance costs of $287	2,140	0
Cash flows provided by financing activities	2,138	946
NET DECREASE IN CASH AND CASH EQUIVALENTS	577	(313)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	698	1,011
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,275	698
Series B1 Preferred Stock [Member]
FINANCING ACTIVITIES
LipimetiX Development, Inc	0	946
Series B2 Preferred Stock [Member]
FINANCING ACTIVITIES
LipimetiX Development, Inc	$ (15)	$ 0